# The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction

> **NCT04972890** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 12 (estimated)

## Conditions studied

- Urologic Diseases
- Erectile Dysfunction With Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** stem cells
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT04972890
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-27
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972890, "The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04972890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
